Clinical implications of postoperative carbohydrate antigen 19-9 as a serological indicator of positive resection margin and occult distant metastasis in patients with resected pancreatic cancer

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2018
This article has no abstract
Epistemonikos ID: 4e1d0fd3a153a9bc788edb14dce2e3141ed12dbf
First added on: Apr 09, 2025